Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III TK-023 Donepezil Patch vs Oral Donepezil in Mild to Moderate Alzheimer's Dementia
jRCT2080224517Phase 3Completed
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of donepezil in Alzheimer's disease (AD) (2 arms), sponsored by Teikoku Seiyaku Co., Ltd. Primary endpoint: Noninferiority of donepezil patch vs oral donepezil on cognitive function. Started Jan 2019; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT2080224517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224517.